These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 28869476

  • 1. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
    Javidnia M, Hebron ML, Xin Y, Kinney NG, Moussa CE.
    J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C, Koo CY, Yankova N, Tavares IA, Wray S, Noble W, Hanger DP, Morris JDH.
    Acta Neuropathol Commun; 2018 May 07; 6(1):37. PubMed ID: 29730992
    [Abstract] [Full Text] [Related]

  • 8. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A, Hunter J, Quadri Z, Zamudio F, Rocha-Rangel PV, Chan D, Kesarwani A, Nash K, Lee DC, Morgan D, Gordon MN, Selenica MB.
    Front Immunol; 2020 May 07; 11():997. PubMed ID: 32508844
    [Abstract] [Full Text] [Related]

  • 9. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
    Lin WL, Lewis J, Yen SH, Hutton M, Dickson DW.
    Am J Pathol; 2003 Jan 07; 162(1):213-8. PubMed ID: 12507904
    [Abstract] [Full Text] [Related]

  • 10. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
    Shen LL, Li WW, Xu YL, Gao SH, Xu MY, Bu XL, Liu YH, Wang J, Zhu J, Zeng F, Yao XQ, Gao CY, Xu ZQ, Zhou XF, Wang YJ.
    Neurobiol Dis; 2019 Dec 07; 132():104567. PubMed ID: 31394202
    [Abstract] [Full Text] [Related]

  • 11. Impaired glutamate transport in a mouse model of tau pathology in astrocytes.
    Dabir DV, Robinson MB, Swanson E, Zhang B, Trojanowski JQ, Lee VM, Forman MS.
    J Neurosci; 2006 Jan 11; 26(2):644-54. PubMed ID: 16407562
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.
    Rockenstein E, Ubhi K, Mante M, Florio J, Adame A, Winter S, Brandstaetter H, Meier D, Masliah E.
    BMC Neurosci; 2015 Nov 26; 16():85. PubMed ID: 26611895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN, Giannopoulos PF, Praticò D.
    Transl Psychiatry; 2017 Dec 18; 7(12):1288. PubMed ID: 29249809
    [Abstract] [Full Text] [Related]

  • 18. Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model.
    Castro-Sánchez S, Zaldivar-Diez J, Luengo E, López MG, Gil C, Martínez A, Lastres-Becker I.
    Neurobiol Aging; 2020 Dec 18; 96():148-154. PubMed ID: 33007689
    [Abstract] [Full Text] [Related]

  • 19. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
    Mewes A, Franke H, Singer D.
    PLoS One; 2012 Dec 18; 7(9):e45017. PubMed ID: 22984603
    [Abstract] [Full Text] [Related]

  • 20. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y, Niu Z, Bryleva EY, Harris BT, Murphy SR, Kheirollah A, Bowen ZD, Chang CCY, Chang TY.
    Neurobiol Aging; 2015 Jul 18; 36(7):2248-2259. PubMed ID: 25930235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.